Defining Treatment Success in Patients With Immune Thrombocytopenia Receiving Thrombopoietin Receptor Agonist Therapy: Results From a Modified Delphi Consensus Panel. Presented at the European Haematology Association meeting 2018

Charlotte Bradbury

Defining Treatment Success in Patients With Immune Thrombocytopenia Receiving Thrombopoietin Receptor Agonist Therapy: Results From a Modified Delphi Consensus Panel. Presented at the European Haematology Association meeting 2018

School of Cellular and Molecular Medicine

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)

Original language	English
Title of host publication	Haematologica
Publication status	Published - 2018

Cite this

@inproceedings{b525317ae4d2484291ab247adf296677,

title = "Defining Treatment Success in Patients With Immune Thrombocytopenia Receiving Thrombopoietin Receptor Agonist Therapy: Results From a Modified Delphi Consensus Panel. Presented at the European Haematology Association meeting 2018",

author = "Charlotte Bradbury",

year = "2018",

language = "English",

booktitle = "Haematologica",

}

Defining Treatment Success in Patients With Immune Thrombocytopenia Receiving Thrombopoietin Receptor Agonist Therapy: Results From a Modified Delphi Consensus Panel. Presented at the European Haematology Association meeting 2018. / Bradbury, Charlotte.

Haematologica. 2018.

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)